Stock listing

Frankfurt:V5Z Sirnaomics Ltd. Aktie

German listing (Frankfurt) of Sirnaomics Ltd. · home listing HKEX:2257

Follow Sirnaomics Ltd. into a list and get an email when it puts out news.

Share price · FWB:V5Z

€0.408 EUR -0.002 (-0.5%)

Close on Oct 16, 2026

Day range
€0.402 – €0.408 EUROct 16, 2026
Market value
€45.42M EURAt the close on Oct 16, 2026 · price × 111.3M shares outstanding
Sirnaomics Ltd. logo
Ticker
Frankfurt:V5Z
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

Discloseable transaction supplemental announcement in relation to deemed disposal of equity interest in a subsidiary and grant of repurchase right

Oct 6, 2026

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026

Oct 6, 2026

Sirnaomics Announces Strategic Equity Investment by Bloomage Biotech to Jointly Advance Next-Generation Life Science Pipelines

Sep 7, 2025

Sirnaomics Has Been Subscribed for 17,527,696 Subscription Shares, New Capital Injection to Promote Business Growth and Development

Oct 4, 2024

Sirnaomics Announces Demonstration of a Novel Mechanism of Action of Its siRNA Therapeutics for Focal Fat Reduction in Journal of Cosmetic Dermatology

Sep 19, 2024

Sirnaomics Announces a Partnership with Gore Range Capital for Establishment of a JV, Sagesse Bio, to Advance Its RNAi Therapeutics into Aesthetic Medicine

Jul 31, 2024

Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy

Jul 24, 2024

Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy for STP125G with NHP Models, Targeting ApoC3 for Treatment of Cardiovascular Diseases

Jul 23, 2024

Sirnaomics Announces Interim Results for Successful Completion of the Second Cohort of Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Therapeutics

Jul 8, 2024

Sirnaomics Announces Completion of STP707 Phase I Clinical Study with Strong Safety Profile and Disease Activity for the Treatment of Pancreatic Cancer Patients

Jun 28, 2024

All Sirnaomics Ltd. news

Financings

  • Strategic investment of equity interest (registered capital) in subsidiary Target Company

    Oct 6, 2026 · US$4.47M

    Closed: CNY 30M raised

    Closed Oct 6, 2026

Read by 6ix AI from the company's releases

Decks

Sirnaomics Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
2 in the last 12 months · 24 in all · newest Oct 6, 2026 · oldest 2023
Decks
2 decks · latest 2024

Where Sirnaomics Ltd. is listed

ListingExchangeCountryCurrency
HKEX:2257 聖諾醫藥 · Home listingHKEXHong KongHKD
Frankfurt:V5Z · This pageFrankfurtGermanyEUR

Log in to ask 6ix AI your own questions about Sirnaomics Ltd.